Next Issue

Table of Contents

Antibodies, Volume 1, Issue 1 (June 2012), Pages 1-123

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-6

Editorial

Jump to: Research, Review

p. 1
by
Antibodies 2012, 1(1), 1; doi:10.3390/antib1010001
Received: 15 December 2011; Accepted: 23 December 2011 / Published: 30 December 2011
Show/Hide Abstract | PDF Full-text (135 KB) | HTML Full-text | XML Full-text

Research

Jump to: Editorial, Review

p. 19-38
by , ,  and
Antibodies 2012, 1(1), 19-38; doi:10.3390/antib1010019
Received: 1 March 2012; in revised form: 28 March 2012 / Accepted: 30 March 2012 / Published: 11 April 2012
Show/Hide Abstract | Cited by 2 | PDF Full-text (800 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Bispecific Antibodies for Dual Targeting Strategies)

Review

Jump to: Editorial, Research

p. 2-18
by ,  and
Antibodies 2012, 1(1), 2-18; doi:10.3390/antib1010002
Received: 28 February 2012; in revised form: 16 March 2012 / Accepted: 30 March 2012 / Published: 10 April 2012
Show/Hide Abstract | Cited by 6 | PDF Full-text (665 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Bispecific Antibodies for Dual Targeting Strategies)
p. 39-69
by  and
Antibodies 2012, 1(1), 39-69; doi:10.3390/antib1010039
Received: 28 March 2012; in revised form: 1 May 2012 / Accepted: 8 May 2012 / Published: 15 May 2012
Show/Hide Abstract | Cited by 3 | PDF Full-text (1096 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Modes of Antibody Action for Cancer Therapy)
p. 70-87
by  and
Antibodies 2012, 1(1), 70-87; doi:10.3390/antib1010070
Received: 27 April 2012; in revised form: 15 May 2012 / Accepted: 17 May 2012 / Published: 31 May 2012
Show/Hide Abstract | Cited by 4 | PDF Full-text (311 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Modes of Antibody Action for Cancer Therapy)
p. 88-123
by ,  and
Antibodies 2012, 1(1), 88-123; doi:10.3390/antib1010088
Received: 19 April 2012; in revised form: 21 May 2012 / Accepted: 24 May 2012 / Published: 1 June 2012
Show/Hide Abstract | Cited by 2 | PDF Full-text (518 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Modes of Antibody Action for Cancer Therapy)
Select/unselect all
Displaying article 1-6
Select articles Export citation of selected articles as:
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert